Boehringer Ingelheim funds Georgia pet adoption center
The Atlanta Humane Society facility opens in a storefront location.
Boehringer Ingelheim Animal Health has given back to its hometown of Duluth, Georgia, by supporting the Atlanta Humane Society’s newest pet adoption center.
The drug maker’s financial donation is an investment in the local community, said Everett Hoekstra, president of Boehringer Ingelheim’s U.S. Animal Health business.
“Boehringer Ingelheim believes in a future where no animal suffers from a preventable disease, and a big part of that involves finding good homes for dogs and cats in need,” Hoekstra said.
The adoption center, located in a corner storefront, celebrated its grand opening Sept. 4. Since opening informally May 1, the Atlanta Humane Society operation has placed more than 320 cats and dogs.
“We’re proud to have partners like Boehringer Ingelheim who care so deeply about animal welfare to join us in furthering our mission,” said Cal Morgan, president and CEO of the Atlanta Humane Society.
Boehringer Ingelheim noted that its backing of the Atlanta Humane Society goes beyond the adoption center. The company also financially supports the organization’s mobile spay-and-neuter service.
Besides Duluth, the drug maker has a presence in Athens and Gainesville, Georgia.